Autologous Stem Cell Transplantation for Crohn's Disease
Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Pediatric and Adult Patients With Severe Crohn's Disease
Paul Szabolcs
20 participants
Jun 26, 2012
INTERVENTIONAL
Conditions
Summary
The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
high-dose immunotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC)
Transplant conditioning
Transplant conditioning
Transplant conditioning
Transplant conditioning
Transplant conditioning
Mobilization
Mobilization
Mobilization
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00692939